{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:05:01Z","timestamp":1777158301478,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3824-7","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:05:33Z","timestamp":1551182733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48\u2009weeks in Yaound\u00e9, Cameroon: a longitudinal cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Bih Hycenta","family":"Chendi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Claire","family":"Okomo Assoumou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme Brendon","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsie Laban","family":"Yekwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Lyonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Mesembe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Eyoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Mondinde","family":"Ikomey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"issue":"Suppl 4","key":"3824_CR1","first-page":"S3","volume":"17","author":"R Pustil","year":"2016","unstructured":"Pustil R. Global AIDS. Aids. 2016;17(Suppl 4):S3\u201311.","journal-title":"Aids"},{"key":"3824_CR2","unstructured":"UNAIDS data 2017. Available online at: \n                    http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20170720_Data_book_2017_en.pdf"},{"key":"3824_CR3","unstructured":"Ministry of Health. National guideline on the prevention and management of HIV in Cameroon, January 2015."},{"key":"3824_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jiph.2013.02.003","volume":"6","author":"SE Pefura-YoneEW","year":"2013","unstructured":"Pefura-YoneEW SE, Kengne AP, Balkissou AD, Kuaban C. Non-adherence to antiretroviral therapy in Yaounde: prevalence, determinants and the concordance of two screening criteria. J Infect Public Health. 2013;6:307\u201315.","journal-title":"J Infect Public Health"},{"key":"3824_CR5","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendation for a public health approach. (2016)."},{"key":"3824_CR6","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/cid\/ciu046","volume":"58","author":"JB Nachega","year":"2014","unstructured":"Nachega JB. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;58:1297\u2013307.","journal-title":"Clin Infect Dis"},{"key":"3824_CR7","doi-asserted-by":"publisher","unstructured":"Segeral O, madec Y, Ban B, Ouk V, Hak CR, Le Tiec C, et al. Simplified assessment of antiretroviral adherence and prediction of virological efficacy in HIV-infected patients in Cambodia. AIDS Res Treat. 2010. \n                    https:\/\/doi.org\/10.1155\/2010\/142076\n                    \n                  .","DOI":"10.1155\/2010\/142076"},{"key":"3824_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0170893","volume":"12","author":"JY Fonsah","year":"2017","unstructured":"Fonsah JY, Njamnshi AK, Kouanfack C, Qiu F, Njamnshi DM, Tagny CT, et al. Adherence to antiretroviral therapy (ART) in Yaound\u00e9-Cameroon: association with opportunistic infections, depression, ART regimen and side effects. PLoS One. 2017;12:1\u201319.","journal-title":"PLoS One"},{"key":"3824_CR9","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/QAI.0b013e318222b5c2","volume":"57","author":"P Roux","year":"2011","unstructured":"Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, Delaporte E, et al. Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods. JAIDS. J Acquir Immune Defic Syndr. 2011;57:S40\u20133.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3824_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3851\/IMP2535","volume":"18","author":"M Meresse","year":"2013","unstructured":"Meresse M, Carrien MP, Laurent C, Kouanfack C, Protopopescu C, Blanche J, et al. Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110\/ ESTHER trial in Cameroon. Antivir Ther. 2013;18:29\u201337.","journal-title":"Antivir Ther"},{"issue":"11","key":"3824_CR11","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00705-015-2583-z","volume":"160","author":"Y Wu","year":"2015","unstructured":"Wu Y, Qiu Y, Yan P, Wang W, Xie M, Zia P, et al. Effectiveness of first-line antiretroviral therapy in HIV\/AIDS patients: a 5-year longitudinal evaluation in Fujian Province, Southeast China. TT. Arch of Vir. 2015;160(11):2693\u2013701.","journal-title":"Arch of Vir"},{"key":"3824_CR12","first-page":"387","volume":"308","author":"MA Thompson","year":"2012","unstructured":"Thompson MA. Antiretroviral Treatment of Adult HIV Infection. Jama. 2012;308:387\u2013402.","journal-title":"Jama"},{"key":"3824_CR13","unstructured":"Tolle MA, Schwarzwald H, Calles NR. Antiretroviral Treatment. Retrieved from\u00a0\n                    https:\/\/bipai.org\/sites\/bipai\/files\/4-Antiretroviral-Treatment.pdf\n                    \n                  . Accessed 10 May 2018."},{"key":"3824_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/QAI.0b013e3181743955","volume":"48","author":"C Kouanfack","year":"2008","unstructured":"Kouanfack C, Laurent C, Peytavin G, Ciaffi L, Ngolle M, Nkene YN, et al. Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in Cameroon. J Acquir Immune Defic Syndr. 2008;48:216\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3824_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/gha.v8.27422","volume":"8","author":"S Dalal","year":"2015","unstructured":"Dalal S, Holmes MD, Laurence C, Bajunirwe F, Guwatudde D, Njelekela M, et al. Feasibility of a large cohort study in sub-Saharan Africa assessed through a four-country study. Glob Health Action. 2015;8:1\u201310.","journal-title":"Glob Health Action"},{"issue":"suppl 1","key":"3824_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4314\/ejhs.v27i1.2S","volume":"27","author":"AM Teklu","year":"2017","unstructured":"Teklu AM, Tsegaye E, Fekade D, Hailemelak A, Weiss W, Hassen E, et al. Establishing a multicenter longitudinal clinical cohort study in Ethiopia: advanced clinical monitoring of antiretroviral treatment project. Ethiop J Health Sci. 2017;27(suppl 1):3\u201316.","journal-title":"Ethiop J Health Sci"},{"key":"3824_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ262","volume":"61","author":"JK Edwards","year":"2015","unstructured":"Edwards JK, Cole SR, Martin JN, Moore R, Mathews WC, Kitahata, et al. Dynamic visual display of treatment response in HIV-infected adults. Clin Infect Dis. 2015;61:e1\u20134.","journal-title":"Clin Infect Dis"},{"key":"3824_CR18","doi-asserted-by":"publisher","unstructured":"Mbuagbaw LC, Irlam JH, Spaulding A, Rutherford GW, Siegfried N. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-na\u00efve individuals. Cochrane Database Syst Rev. 2016. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004246.","DOI":"10.1002\/14651858.CD004246."},{"key":"3824_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7448\/IAS.19.1.20773","volume":"19","author":"B Castelnuovo","year":"2016","unstructured":"Castelnuovo B, Kiragga A, Mubiru F, Kambbuyu A, Kamya M, Reynolds SJ. First-line antiretroviral therapy durability in a 10-year cohort of na\u00efve adults started on treatment in Uganda. J Int AIDS Soc. 2016;19:1\u20136.","journal-title":"J Int AIDS Soc"},{"key":"3824_CR20","doi-asserted-by":"crossref","unstructured":"Shearer K, Brennan AT, Maskew M, Long L, Berhanu R, Sanne I. The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa. J Int AIDS Soc. 2014;17(1):\u201310.","DOI":"10.7448\/IAS.17.1.19065"},{"key":"3824_CR21","doi-asserted-by":"crossref","unstructured":"Pillay P, Ford N, Shubber Z, Ferrand RA. Outcomes for Efavirenz versus Nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and Meta-analysis. PLoS One. 2013;8.","DOI":"10.1371\/journal.pone.0068995"},{"key":"3824_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/jac\/dku470","volume":"70","author":"A Zoufaly","year":"2015","unstructured":"Zoufaly A, Jochum J, Hammerl R, Nassimi N, Raymond Y, burchard GD. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon. J Antimicrob Chemother. 2015;70:922\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"3824_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1258\/ijsa.2011.011292","volume":"23","author":"A Buscher","year":"2012","unstructured":"Buscher A, Hartman C, Kallen MA, Giordano TP. Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, HAART na\u00efve, HIV patients. Int J STD AIDS. 2012;23(5):351\u20135. \n                    https:\/\/doi.org\/10.1258\/ijsa.2011.011292\n                    \n                  .","journal-title":"Int J STD AIDS"},{"issue":"2","key":"3824_CR24","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/QAI.0000000000000580","volume":"69","author":"W Ochieng","year":"2015","unstructured":"Ochieng W, Kitawi RC, Nzomo TJ, Mwatelah RS, Kimulwo MJ, Ochieng DJ, et al. Correlates of adherence and treatment failure among kenyan patients on long term highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;69(2):e49\u201356.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3824_CR25","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1086\/313849","volume":"30","author":"MA Chesney","year":"2000","unstructured":"Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30:S171\u20136.","journal-title":"Clin Infect Dis"},{"key":"3824_CR26","doi-asserted-by":"publisher","unstructured":"Ghidei L, Simone M, Salow M, Zimmerman K, Paquin AM, Skarf M, et al. Aging, antiretroviral and adherence: a meta analysis of adherence among older hiv infected individuals. NIH-PA. 2013;30(10). \n                    https:\/\/doi.org\/10.1007\/s40266-013-0107-7\n                    \n                  .","DOI":"10.1007\/s40266-013-0107-7"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3824-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3824-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3824-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:13:31Z","timestamp":1582676011000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3824-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3824"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3824-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Cameroon National Ethics Committee for Human Health Research with reference number: N<sup>\u00b0<\/sup>2016\/10\/829\/CE\/CNERSH\/SP. All participants signed a written consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"194"}}